Post-SARS-CoV-2 Vaccination Late Gadolinium Enhancement Not Only Suggests Myocarditis
IAR-Medical Series · 2021
DOI: 10.47310/iarms.2021.v02i02.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift IAR-Medical Series, 2021. Verfasst von Josef Finsterer und 1 weiteren Autor:innen.
Abstract (Originalsprache)
We read with interest the article by d’Angelo et al. about a 30yo male diagnosed with myocarditis 3d after the second dose of an mRNA-based SARS-CoV-2 vaccine upon sub-epicardial late gadolinium enhancement (LGE) on cardiac MRI [1]. Symptoms resolved upon acetyl-salicylic acid, bisoprolol, and steroids [1]. It was concluded that clinicians should remain vigilant and suspect myocarditis in patients with cardiopulmonary symptoms after recent SARS-CoV-2 vaccinations [1]. The study is appealing but raises concerns.
Zitieren
APA
Finsterer, J., & Stöllberger, C. (2021). Post-SARS-CoV-2 Vaccination Late Gadolinium Enhancement Not Only Suggests Myocarditis. IAR-Medical Series. https://doi.org/10.47310/iarms.2021.v02i02.001
Vancouver
Finsterer J, Stöllberger C. Post-SARS-CoV-2 Vaccination Late Gadolinium Enhancement Not Only Suggests Myocarditis. IAR-Medical Series. 2021. doi:10.47310/iarms.2021.v02i02.001
BibTeX
@article{Finsterer2021,
author = {Finsterer, Josef and Stöllberger, Claudia},
title = {Post-SARS-CoV-2 Vaccination Late Gadolinium Enhancement Not Only Suggests Myocarditis},
journal = {IAR-Medical Series},
year = {2021},
doi = {10.47310/iarms.2021.v02i02.001}
}
EUVIMED